Rituximab in neuroinflammatory conditions: the evidence available and prescribing advice

episode

Practical Neurology Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-26-2026 9PM EDT 4 min · 27 Sep 2026 · NPR News Now

9PM ET 09/26/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

SMART FOOD HACKS || Cool Food Hacks We Found On Tik Tok by 123 GO! 10 min · 27 Sep 2026 · 123 GO!

DIY WAYS TO REUSE OLD THINGS || Funny Crafts Ideas by 123 GO! 9 min · 27 Sep 2026 · 123 GO!

HOW TO BRING FOOD ANYWHERE YOU GO || Cool Food To The Movie Hacks by 123 GO! 12 min · 27 Sep 2026 · 123 GO!

Trump Rejects Deal to Reopen Hormuz, East Coast Nor’easter, More 7 min · 27 Sep 2026 · Bloomberg News Now

Report any issue

Source

Recorded15 Jan 2019

Publisherfeed.podbean.com ↗

Handlerec:13247426

Show notes

The basic principles of B-cell depletion with therapeutic monoclonal antibodies, the available evidence for using rituximab in neurological diseases as well as prescribing advice are discussed in this podcast. Practical Neurology Associate Editor Dr Tom Hughes is joined by Dr Daniel Whittam and Dr Anu Jacob, the authors of the review paper: “Rituximab in neurological disease: principles, evidence and practice”, which is part of the Practical Neurology February issue (https://pn.bmj.com/content/19/1/5).

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in